Page last updated: 2024-11-04

succinylcholine and Electron Transport Chain Deficiencies, Mitochondrial

succinylcholine has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 2 studies

Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.

Research Excerpts

ExcerptRelevanceReference
"The findings include the mechanisms of the hyperkalemia after succinylcholine in patients with upregulation of acetylcholine receptors."4.84Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist? ( Driessen, JJ, 2008)
"MD is not at increased risk for malignant hyperthermia and should not be managed with prolonged propofol infusion."2.82Anesthetic Management of the Patient with Mitochondrial Disease: A Review of Current Best Evidence. ( Brody, KM, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Brody, KM1
Driessen, JJ1

Reviews

2 reviews available for succinylcholine and Electron Transport Chain Deficiencies, Mitochondrial

ArticleYear
Anesthetic Management of the Patient with Mitochondrial Disease: A Review of Current Best Evidence.
    AANA journal, 2022, Volume: 90, Issue:2

    Topics: Anesthesia; Anesthetics, General; Humans; Malignant Hyperthermia; Mitochondrial Diseases; Succinylch

2022
Neuromuscular and mitochondrial disorders: what is relevant to the anaesthesiologist?
    Current opinion in anaesthesiology, 2008, Volume: 21, Issue:3

    Topics: Anesthesiology; Anesthetics, Inhalation; Anesthetics, Intravenous; Humans; Hyperkalemia; Malignant H

2008